Author:
Turner Avenelle I.,Hahn Kevin A.,Rusk Anthony,Gamblin Ranee M.,Cosgrove Sallie B.,Griffice Kelly,Khanna Chand
Reference34 articles.
1. Gemcitabine: Metabolism, mechanism of action, and self potentiation;Plunkett;Semin Oncol,1995
2. Nucleoside analogues: Mechanisms of drug resistance and reversal strategies;Galmarini;Leukemia,2001
3. Toxicity and pharmacokinetics of intravesical gemcitabine: A preclinical study in dogs;Cozzi;Clin Cancer Res,1999
4. Metabolism and disposition of gemcitabine and oncolytic deoxycytidine analog, in mice, rats and dogs;Shipley;Drug Metab Dispos,1992
5. Combination of low-dose cisplatin and Gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer;Feliu;Cancer Chemother Pharmacol,2003
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Histone Deacetylase Inhibitor Entinostat/Syndax 275 in Osteosarcoma;Advances in Experimental Medicine and Biology;2020
2. Hematopoietic Tumors;Withrow and MacEwen's Small Animal Clinical Oncology;2019
3. Cancer Chemotherapy;Withrow and MacEwen's Small Animal Clinical Oncology;2019
4. Update on Cancer Treatment in Exotics;Veterinary Clinics of North America: Exotic Animal Practice;2018-05
5. Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses;Veterinary and Comparative Oncology;2017-09-11